Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC)
Oncotarget · 2023-02-02 · 14 (1) · 85-95
DOI: 10.18632/oncotarget.28355 ↗At a glance
Journal article in Oncotarget, published online on 2023-02-02. Written by Md Maksudul Alam and 10 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, LSU-Health Sciences Center, Shreveport, LA 71103, USA. Major MEDLINE topics: Everolimus, Head and Neck Neoplasms. Cited 23 times so far (Crossref); 46 references. The full text is freely available in PubMed Central.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otolaryngology-Head and Neck Surgery, LSU-Health Sciences Center, Shreveport, LA 71103, USA.
- School of Medicine, LSU-Health Sciences Center, Shreveport, LA 71103, USA.
- Feist-Weiller Cancer Center, LSU-Health Sciences Center, Shreveport, LA 71103, USA.
Cite
APA
Alam, M. M., Fermin, J. M., Knackstedt, M., Noonan, M. J., Powell, T., Goodreau, L., Daniel, E. K., Rong, X., Moore-Medlin, T., Khandelwal, A. R., & Nathan, C. O. (2023). Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC). Oncotarget, 14(1), 85-95. https://doi.org/10.18632/oncotarget.28355
Vancouver
Alam MM, Fermin JM, Knackstedt M, Noonan MJ, Powell T, Goodreau L, et al. Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC). Oncotarget. 2023;14(1):85-95. doi:10.18632/oncotarget.28355
BibTeX
@article{Alam2023,
author = {Alam, Md Maksudul and Fermin, Janmaris Marin and Knackstedt, Mark and Noonan, Mackenzie J and Powell, Taylor and Goodreau, Landon and Daniel, Emily K and Rong, Xiaohua and Moore-Medlin, Tara and Khandelwal, Alok R and Nathan, Cherie-Ann O},
title = {Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC)},
journal = {Oncotarget},
year = {2023},
volume = {14},
number = {1},
pages = {85--95},
doi = {10.18632/oncotarget.28355}
}
EUVIMED